A detailed history of Canandaigua National Bank & Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 12,903 shares of AMGN stock, worth $4.02 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
12,903
Previous 13,007 0.8%
Holding current value
$4.02 Million
Previous $3.75 Million 2.08%
% of portfolio
0.58%
Previous 0.63%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 01, 2024

SELL
$268.87 - $324.56 $27,962 - $33,754
-104 Reduced 0.8%
12,903 $3.67 Million
Q4 2023

Jan 04, 2024

SELL
$255.7 - $288.46 $85,148 - $96,057
-333 Reduced 2.5%
13,007 $3.75 Million
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $27,112 - $33,661
-124 Reduced 0.92%
13,340 $3.59 Million
Q2 2023

Jul 03, 2023

BUY
$214.27 - $253.37 $84,208 - $99,574
393 Added 3.01%
13,464 $2.99 Million
Q1 2023

Apr 11, 2023

BUY
$225.79 - $275.2 $39,739 - $48,435
176 Added 1.36%
13,071 $3.16 Million
Q1 2020

Apr 16, 2020

BUY
$182.24 - $241.7 $91,666 - $121,575
503 Added 4.06%
12,895 $2.61 Million
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $18,353 - $23,590
-97 Reduced 0.78%
12,392 $2.99 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $448,681 - $537,613
2,577 Added 26.0%
12,489 $2.42 Million
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $1,333 - $1,563
8 Added 0.08%
9,912 $1.83 Million
Q1 2019

Apr 25, 2019

BUY
$180.87 - $203.88 $43,227 - $48,727
239 Added 2.47%
9,904 $1.88 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $95,622 - $111,622
536 Added 5.87%
9,665 $1.88 Million
Q3 2018

Nov 02, 2018

BUY
$185.29 - $208.89 $183,251 - $206,592
989 Added 12.15%
9,129 $1.89 Million
Q2 2018

Aug 03, 2018

BUY
$166.05 - $186.51 $2,822 - $3,170
17 Added 0.21%
8,140 $1.5 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $1.38 Million - $1.61 Million
8,123 New
8,123 $1.39 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Canandaigua National Bank & Trust CO Portfolio

Follow Canandaigua National Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.